Read our blog, GLP-1 Medications, Cravings, and Body Autonomy , to learn more about this evolving perspective
Continue protein, steps, and training
The practice took off in the summer of 2024
By blocking TREK-1, PE-22-28: Increases neuronal excitability : Reduces potassium efflux, depolarizing neurons toward firing threshold Enhances serotonergic transmission : TREK-1 is expressed on serotonergic neurons in the dorsal raphe nucleus
Treatments you can trust Free consultations, free shipping and free on-going support from licensed providers nationwide
Mounjaro: A New GLP-1 Agonist For Weight Loss and Type 2 Diabetes A breakthrough in diabetes management and weight loss , Mounjaro (tirzepatide) is gaining attention in the role of a dual-action medication